IRIS
RENDA, GIULIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.952
AS - Asia 5.290
EU - Europa 4.583
SA - Sud America 908
Continente sconosciuto - Info sul continente non disponibili 697
AF - Africa 85
OC - Oceania 4
Totale 21.519
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.585
SG - Singapore 2.240
CN - Cina 1.296
IT - Italia 858
BR - Brasile 741
IE - Irlanda 690
UA - Ucraina 645
RU - Federazione Russa 614
VN - Vietnam 545
TR - Turchia 503
SE - Svezia 494
GB - Regno Unito 370
DE - Germania 287
FR - Francia 216
FI - Finlandia 160
CA - Canada 146
BD - Bangladesh 134
IN - India 123
HK - Hong Kong 101
AR - Argentina 68
MX - Messico 63
PL - Polonia 52
IQ - Iraq 43
ID - Indonesia 42
CR - Costa Rica 40
JP - Giappone 39
NL - Olanda 35
AT - Austria 30
EC - Ecuador 30
ZA - Sudafrica 28
IL - Israele 27
IR - Iran 27
ES - Italia 26
BE - Belgio 23
PK - Pakistan 23
LT - Lituania 22
CO - Colombia 19
KR - Corea 19
VE - Venezuela 19
GT - Guatemala 18
PH - Filippine 17
EG - Egitto 16
SV - El Salvador 16
HN - Honduras 15
GP - Guadalupe 13
JO - Giordania 13
TT - Trinidad e Tobago 13
UZ - Uzbekistan 13
AE - Emirati Arabi Uniti 12
JM - Giamaica 12
NP - Nepal 12
MY - Malesia 11
NI - Nicaragua 11
PY - Paraguay 11
EU - Europa 10
CL - Cile 9
CZ - Repubblica Ceca 9
SC - Seychelles 9
PR - Porto Rico 8
SA - Arabia Saudita 8
CW - ???statistics.table.value.countryCode.CW??? 7
EE - Estonia 7
KZ - Kazakistan 7
RO - Romania 7
KE - Kenya 6
MA - Marocco 6
OM - Oman 6
CH - Svizzera 5
HU - Ungheria 5
TN - Tunisia 5
UY - Uruguay 5
BH - Bahrain 4
DK - Danimarca 4
DZ - Algeria 4
AU - Australia 3
BB - Barbados 3
DO - Repubblica Dominicana 3
GR - Grecia 3
LB - Libano 3
SN - Senegal 3
AL - Albania 2
AM - Armenia 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BN - Brunei Darussalam 2
BO - Bolivia 2
BS - Bahamas 2
GD - Grenada 2
GE - Georgia 2
GY - Guiana 2
LV - Lettonia 2
MD - Moldavia 2
MK - Macedonia 2
NE - Niger 2
PA - Panama 2
PE - Perù 2
PS - Palestinian Territory 2
RS - Serbia 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
Totale 20.815
Salva come PNG Salva come JPEG
Città #
Singapore 1.600
San Jose 974
Dallas 893
Jacksonville 758
Dublin 672
Chandler 649
Ashburn 582
Council Bluffs 488
Princeton 337
Beijing 297
Los Angeles 239
Izmir 224
Ho Chi Minh City 202
Nanjing 201
Southend 196
Santa Clara 189
New York 157
Buffalo 132
Hanoi 129
Altamura 118
Cambridge 118
Dearborn 117
Wilmington 113
Tongling 107
The Dalles 104
Hong Kong 98
North Bergen 88
Nanchang 87
Ann Arbor 79
Phoenix 79
Chieti 71
São Paulo 68
Moscow 64
Redondo Beach 59
Columbus 57
Munich 56
Pescara 52
Brooklyn 48
Chicago 46
Montreal 44
Boardman 41
Denver 41
Orem 41
Atlanta 39
Hebei 39
Shenyang 39
Washington 39
Woodbridge 39
Milan 38
Houston 37
San Francisco 37
Tokyo 37
Kunming 35
Rome 35
Hefei 34
Toronto 32
Warsaw 30
San José 29
Tianjin 29
Augusta 28
Norwalk 27
Haiphong 25
London 25
Changsha 24
Da Nang 24
Rio de Janeiro 24
Stockholm 24
Jiaxing 23
San Mateo 23
Brasília 22
Brussels 22
Grevenbroich 22
Johannesburg 22
Mexico City 22
Seattle 22
Lappeenranta 21
Leawood 20
Helsinki 19
Amsterdam 18
Ardabil 17
Boston 17
Camerino 17
Frankfurt am Main 17
Nuremberg 17
Teramo 17
Ankara 16
Baghdad 16
Hangzhou 16
League City 16
Naples 16
Bologna 15
Chennai 15
Dong Ket 15
Falls Church 15
Guatemala City 15
Hải Dương 15
Kimball 15
Kraków 15
Poplar 15
Belo Horizonte 14
Totale 12.071
Salva come PNG Salva come JPEG
Nome #
Celecoxib, ibuprofen, and the antiplatelet effect of aspirin in patients with osteoarthritis and ischemic heart disease 442
Low-dose naproxen interferes with the antiplatelet effects of aspirin in healthy subjects: recommendations to minimize the functional consequences 425
Pharmacodynamic interaction of naproxen with low-dose aspirin in healthy subjects 386
Cardiovascular Morbidity and Mortality Related to Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis 200
Increased left atrial size in obese children and its association with insulin resistance: a pilot study 190
Effects of endurance, resistance and neuro-muscular electrical stimulation trainings to the anthropometric and functional mobility domains in elderly 188
Valvular Heart Disease Patients on Edoxaban or Warfarin in the ENGAGE AF-TIMI 48 Trial 185
Response to "Pharmacodynamic Interaction Between Aspirin and Ibuprofen: A Plausible Mechanism of Aspirin Resistance" 178
The Role of Multimodality Cardiovascular Imaging in Peripartum Cardiomyopathy 174
Genetic determinants of blood pressure responses to caffeine drinking 171
Heterogeneity in the suppression of platelet cyclooxygenase-1 activity by aspirin in coronary heart disease 170
La gestione del rischio tromboembolico nei pazienti con fibrillazione atriale in Italia: Dati al follow-up del Registro Europeo PREFER in AF 167
Awake systolic blood pressure variability correlates with target-organ damage in hypertensive subjects 166
Heart failure subtypes and thromboembolic risk in patients with atrial fibrillation: The PREFER in AF - HF substudy 162
Predictive Value of Echocardiographic Pulmonary to Left Atrial Ratio for In-Hospital Death in Patients with COVID-19 160
Role of CES1 and ABCB1 Genetic Polymorphisms on Functional Response to Dabigatran in Patients with Atrial Fibrillation 159
Optimal duration of antiplatelet therapy in recipients of coronary drug-eluting stents 159
Echocardiographic screening for the anomalous aortic origin of coronary arteries 158
Failure in evoking the trigeminal cardiac reflex by mandibular stretching in healthy volunteers 157
Intracardiac thrombi during warfarin anticoagulation - A case report and a brief literature review 152
Surgical bleeding after pre-operative unfractionated heparin and low molecular weight heparin for coronary bypass surgery 147
Rapid decline of collateral circulation increases susceptibility to myocardial ischemia: the trade-off of successful percutaneous recanalization of chronic total occlusions 146
Risk of Atrial Fibrillation in Masked and White Coat Uncontrolled Hypertension 144
Genetic determinants of cognitive responses to caffeine drinking identified from a double-blind, randomized, controlled trial 141
Antithrombotic management and outcomes of patients with atrial fibrillation treated with NOACs early at the time of market introduction: Main results from the PREFER in AF Prolongation Registry 141
Prevention of cardiotoxicity in childhood cancer survivors: in physical exercise, we trust 140
Dose-dependent inhibition of platelet cyclooxygenase-1 and monocyte cyclooxygenase-2 by meloxicam in healthy subjects 139
Antithrombotic therapy after percutaneous coronary intervention of bifurcation lesions 139
A real-world multicenter study on left atrial appendage occlusion: The Italian multi-device experience 138
Prevention of atherothrombotic events in patients with diabetes mellitus: from antithrombotic therapies to new-generation glucose-lowering drugs 138
Facilitated PCI: Rationale, current evidence, open questions and future directions 137
Aspirin-triggered lipoxin in patients treated with aspirin and selective vs. nonselective COX-2 inhibitors 137
Predialysis and Dialysis Therapies Differently Affect Nitric Oxide Synthetic Pathway in Red Blood Cells from Uremic Patients: Focus on Peritoneal Dialysis 137
Platelet Indices and Risk of Death and Cardiovascular Events: Results from a Large Population-Based Cohort Study 135
Aneurisma coronarico: scoperta generalmente casuale, prognosi sempre severa? 134
Contribution of Atrial Fibrillation to In-Hospital Mortality in Patients With COVID-19 134
Ex Vivo Antiplatelet Effects of Oral Anticoagulants 133
Ambulatory blood pressure and risk of new-onset atrial fibrillation in treated hypertensive patients 133
Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Disease 132
Predictive Value of Left Atrial and Ventricular Strain for the Detection of Atrial Fibrillation in Patients With Cryptogenic Stroke 130
Aspirin-triggered lipoxin in patients treated with aspirin and selective vs. non-selective COX-2 inhibitors 130
Coffee: Health Effects 130
Thrombotic and hemorrhagic burden in women: Gender-related issues in the response to antithrombotic therapies 130
Prognostic value of non-resistant and resistant masked uncontrolled hypertension detected by ambulatory blood pressure monitoring 130
Clinical outcome with different doses of low-molecular-weight heparin in patients hospitalized for COVID-19 129
Edoxaban for the Prevention of Thromboembolism in Patients with Atrial Fibrillation and Bioprosthetic Valves 128
Direct Oral Anticoagulants Halve Thromboembolic Events After Cardioversion of AF Compared With Warfarin 128
The legacy of ISCHEMIA 128
EFFECTS OF NIMESULIDE ON CONSTITUTIVE AND INDUCIBLE PROSTANOID BIOSYNTHESIS IN MAN. 127
Incomplete suppression of platelet COX-1 activity associated with aspirin-resistant thromboxane biosynthesis in acute coronary syndromes 127
Cardiovascular and psychological reactivity after caffeine consumption 127
The left atrial appendage: from embryology to prevention of thromboembolism 126
Antithrombotic Therapy in Patients Undergoing Transcatheter Interventions for Structural Heart Disease 126
Dose- Dependent inhibition of platelet cyclooxygenase-1 and monocyte cyclooxygenase-2 by meloxicam in healthy subjects. 125
Outcomes of anticoagulated patients with atrial fibrillation treated with or without antiplatelet therapy - A pooled analysis from the PREFER in AF and PREFER in AF PROLONGATON registries 125
Revisiting Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Current Practice and Novel Perspectives 124
Increased thromboxane production by monocyte prostaglandin endoperoxide synthase-2 in patients with acute myocardial infarction (pubbl. su Suppl. Circulation) 124
Prognostic Significance of Chest Imaging by LUS and CT in COVID-19 Inpatients: The ECOVID Multicenter Study 124
Management of thromboembolic risk in patients with atrial fibrillation in Italy: baseline data from the PREFER in AF European Registry 123
Insulin-Requiring Versus Noninsulin-Requiring Diabetes and Thromboembolic Risk in Patients With Atrial Fibrillation: PREFER in AF 122
Sex Implications in the Response to Anticoagulant Therapy in Atrial Fibrillation ∗ 122
CHA2DS2VASc score and adverse outcomes in middle-aged individuals without atrial fibrillation 122
An early decline of collateral circulation parallels myocardial ischaemia during percutaneous coronary intervention: a drawback of recanalization of chronic coronary occlusions? 121
Antithrombotic therapy in atrial fibrillation: state of the art and perspectives. 121
Quality of life and patient satisfaction in patients with atrial fibrillation on stable vitamin K antagonist treatment or switched to a non-vitamin K antagonist oral anticoagulant during a 1-year follow-up: A PREFER in AF Registry substudy 121
Predictors of Mortality and Cardiovascular Outcome at 6 Months after Hospitalization for COVID-19 121
The AVERROES Trial – Clinical Implications 119
Blood pressure modifications after caffeine intake during cognitive tasks 118
Autonomic nervous system dysfunction in obese children 118
Cardiovascular effects of caffeine during cognitive tasks 118
Enhanced thromboxane biosynthesis in patients with colorectal and lung cancer 118
Non-vitamin K Antagonist Oral Anticoagulants for Cardioversion in Atrial Fibrillation - An Updated Meta-analysis 118
Net Clinical Benefit of Non-Vitamin K Antagonist vs Vitamin K Antagonist Anticoagulants in Elderly Patients with Atrial Fibrillation 118
History of bleeding and outcomes with apixaban versus warfarin in patients with atrial fibrillation in the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial 118
Preeclampsia: Insights into pathophysiological mechanisms and preventive strategies 117
Celecoxib, ibuprofen and the antiplatelet effect of aspirin in patients with osteoarthritis and chronic stable angina 117
Frequent and possibly inappropriate use of combination therapy with an oral anticoagulant and antiplatelet agents in patients with atrial fibrillation in Europe. 117
Mortality predictors and effects of antithrombotic therapies in atrial fibrillation: insights from ACTIVE-W 116
Systolic and diastolic dysfunction occurs in newly diagnosed patients with hypertension and high systolic blood pressure variability 115
INCREASED THROMBOXANE PRODUCTION BY MONOCYTE PROSTAGLANDIN ENDOPEROXIDE SYNTHASE-2 IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION. 114
New anticoagulants for atrial fibrillation 113
Effect of fibrinogen concentration and platelet count on the inhibitory effect of abciximab and tirofiban 113
Ruolo del fibrinogeno e della conta piastrinica sull’inibizione dell’aggregazione piastrinica da parte dei farmaci anti-glicoproteina IIbIIIa 113
Thromboembolic and bleeding risk in obese patients with atrial fibrillation according to different anticoagulation strategies 113
Tracing Visual Expertise in ECG Interpretation: An Eye‐Tracking Pilot Study 112
MECHANISMS OF ISOPROSTANE BIOSYNTHESIS IN HUMANS 112
Atrial and left atrial appendage thrombosis in patients with atrial fibrillation: from pathophysiology to treatment 112
PrevenTion of contrast-inducEd nephropAThy with urinE alkalinization: the TEATE study design 111
Nutrigenetics of blood pressure responses to coffee drinking 110
Platelet function and long-term antiplatelet therapy in women: is there a gender-specificity? A 'state-of-the-art' paper 110
ENHANCED CORTISOL SECRETION DOES NOT CONTROL ASPIRIN-INSENSITIVE THROMBOXANE BIOSYNTHESIS IN PATIENTS WITH ACUTE CORONARY SYNDROMES 109
AF: current and forthcoming antithrombotic therapies 108
Case Report: Mitral Valve Involvement and First-Degree Atrial-Ventricular Block in Two Patients With Multisystem Inflammatory Syndrome in Children 108
Managing drug–drug interactions with mavacamten: A focus on combined use of antiarrhythmic drugs and anticoagulants 107
Aspirin-triggered lipoxin in patients treated with aspirin and selective vs. non-selective COX-2 inhibitors 107
Prognostic significance of noncardiac syncope in the general population: A systematic review and meta-analysis 107
Awake blood pressure variability, inflammatory markers and target organ damage in newly diagnosed hypertension 106
Measurements of thromboxane production and their clinical significance in coronary heart disease 106
Systolic blood pressure variability by non-invasive monitoring predicts intima-media thickness independent of absolute blood pressure levels 106
Systolic and diastolic dysfunction occurs in newly diagnosed patients with hypertension and high systolic blood pressure variability 106
Totale 13.995
Salva come PNG Salva come JPEG
Categoria #
all - tutte 86.152
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 86.152
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022543 0 0 0 0 82 8 17 62 64 18 71 221
2022/20232.004 182 282 117 193 181 391 139 137 268 23 51 40
2023/2024961 75 17 57 11 51 299 221 46 11 29 30 114
2024/20252.732 168 442 348 83 61 96 88 124 314 192 303 513
2025/20267.423 485 291 1.271 995 624 390 977 422 739 562 516 151
2026/20273.200 286 543 940 1.013 418 0 0 0 0 0 0 0
Totale 21.519